Healthcare Services

Growing Demand For Biologics On Mammalian Cell Fermentation Technology Market Is Supporting Development Across The Mammalian Cell Fermentation Technology Market

June 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Will The Market Value Of The Mammalian Cell Fermentation Technology Market Increase Between 2026 And 2030?

The mammalian cell fermentation technology market has experienced rapid expansion in recent years. Its valuation is projected to increase from $57.37 billion in 2025 to $64.07 billion in 2026, advancing at a compound annual growth rate (CAGR) of 11.7%. Historically, this market’s development is largely attributable to the growth of monoclonal antibody therapeutics, the early success of mammalian cell expression systems, a rise in biopharmaceutical approvals, the dependence on batch-based fermentation processes, and the expansion of academic research in cell culture technologies.

The mammalian cell fermentation technology market size is projected for significant expansion in the coming years. This market is predicted to reach $94.89 billion by 2030, achieving a compound annual growth rate (CAGR) of 10.3%. Factors contributing to this expansion during the forecast period include the increasing demand for biologics and biosimilars, greater investment in cell line engineering, the advancement of personalized medicine, the expansion of vaccine development pipelines, and enhanced biomanufacturing capabilities in developing regions. Key trends anticipated in the forecast period encompass a greater embrace of CHO cell-based production platforms, a surging need for high-yield and scalable bioprocessing, increased outsourcing to CDMOs for biologic manufacturing, the proliferation of single-use and modular bioreactor systems, and an intensified focus on optimizing processes and ensuring yield consistency.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16473&type=smp

Which Growth Drivers Are Expected To Support The Mammalian Cell Fermentation Technology Market Forward?

The increasing need for biologics is anticipated to boost the expansion of the mammalian cell fermentation technology market moving ahead. These medical products, known as biologics, originate from living organisms or their constituents and are frequently employed in managing conditions like cancer, autoimmune disorders, and infectious diseases. The rising demand for biologics stems from breakthroughs in biotechnology, their efficacy in addressing widespread chronic illnesses like cancer and autoimmune disorders, favorable regulatory endorsements, and increased funding for research and development. Mammalian cell fermentation technology efficiently facilitates the production of intricate biologics, thereby satisfying the escalating requirement for tailored and specific therapeutic interventions. Its capacity for scalability, adaptability, and the capability to yield superior proteins stimulate innovation within the biopharmaceutical sector. As an illustration, the National Library of Medicine, a US medical library, reported that in February 2024, the Food and Drug Administration (FDA) had approved 55 new drugs in 2023, comprising 29 new chemical entities (NCEs) and 25 new biological entities (NBEs). This represented a 50% increase compared to the 37 approvals observed in 2022. Consequently, the increasing need for biologics is propelling the expansion of the bacterial cell fermentation technology market.

How Is The Mammalian Cell Fermentation Technology Market Structured Across Different Market Segments?

The mammalian cell fermentation technology market covered in this report is segmented –

1) By Type: Chinese Hamster Ovary Cell Fermentation, Human Embryonic Kidney Cell Fermentation, Baby Hamster Kidney Cell Fermentation, Murine Myeloma Cell Fermentation, Other Types

2) By Application: Monoclonal Antibodies, Recombinant Proteins, Vaccines, Hormones, Enzymes, Other Applications

3) By End-Use: Biopharmaceutical Companies, Contract Research Organizations And Contract Development and Manufacturing Organizations, Academic And Research Institutes

Subsegments:

1) By Chinese Hamster Ovary (CHO) Cell Fermentation: Suspension CHO Cell Lines, Serum-Free CHO Fermentation, High-Yield Recombinant Protein Production

2) By Human Embryonic Kidney (HEK) Cell Fermentation: Transient Transfection-Based Fermentation, Viral Vector Production Systems, Serum-Free HEK Cell Cultures

3) By Baby Hamster Kidney (BHK) Cell Fermentation: Vaccine Antigen Production, Stable Cell Line Fermentation, Suspension BHK Cell Cultures

4) By Murine Myeloma Cell Fermentation: Monoclonal Antibody Production, Hybridoma-Based Fermentation, Serum-Free Antibody Expression Systems

5) By Other Types: Insect Cell Line Fermentation, Stem Cell–Derived Mammalian Cells, Custom Engineered Cell Line Fermentation

What Trends Are Shaping The Mammalian Cell Fermentation Technology Market Structure?

Leading companies active in the mammalian cell fermentation technology market are concentrating on developing innovative methods, such as mammalian cell culture, to solidify their market presence. Mammalian cell culture is an essential tool in various sectors, including biomanufacturing, research, and regenerative medicine, as it facilitates the creation of therapeutic proteins, vaccines, and functional cells or tissue analogs. For instance, in June 2024, Syntegon, a Germany-based biotechnology firm, unveiled its new Modular Bioprocessing Platform (MBP) at Achema 2024, specifically designed to overcome key difficulties in biopharmaceutical production. This groundbreaking platform offers a highly flexible, fully integrated, and automated solution suitable for a wide range of applications, including microbial and mammalian cell cultures, proteins, peptides, oligonucleotides, plasmid DNA, and recombinant vaccines. The MBP’s modular architecture allows for reduced lead times and lower costs while maintaining high functionality and quality, in line with the “made in Germany” standard. Its prefabricated cleanroom design positions all peripheral technology outside the cleanroom, thereby boosting efficiency and simplifying maintenance procedures.

Which Organizations Are Involved In The Mammalian Cell Fermentation Technology Market?

Major companies operating in the mammalian cell fermentation technology market are AbbVie Inc., Thermo Fisher Scientific Inc, AstraZeneca PLC, Roche Holdings Inc., Merck KGaA, AGC Group, Lonza Group Ltd., Boehringer Ingelheim GmbH, Catalent Inc., Sartorius AG, Samsung Biologics Co. Ltd., WuXi Biologics, Biocon Limited, Eppendorf AG, KBI Biopharma Inc., Fujifilm Diosynth Biotechnologies, Avid Bioservices Inc., BiOZEEN, Nordmark Pharma GmbH, Scorpius BioManufacturing Inc

Access The Complete Mammalian Cell Fermentation Technology Market Report:

https://www.thebusinessresearchcompany.com/report/mammalian-cell-fermentation-technology-global-market-report

Which Regional Market Leads The Mammalian Cell Fermentation Technology Market?

North America was the largest region in the mammalian cell fermentation technology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mammalian cell fermentation technology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Mammalian Cell Fermentation Technology Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=16473&type=smp

Browse Through More Reports Similar to the Global Mammalian Cell Fermentation Technology Market 2026, By The Business Research Company

Primary Cell Culture Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/primary-cell-culture-global-market-report

Cell Culture Media Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/cell-culture-media-global-market-report

Cell Cultures Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/cell-cultures-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795